Literature DB >> 18633484

Stress-related and spontaneous stage differentiation of Toxoplasma gondii.

Marialice da Fonseca Ferreira da Silva1, Helene S Barbosa, Uwe Gross, Carsten G K Lüder.   

Abstract

Toxoplasma gondii is an obligatory intracellular parasitic protozoan that infects a variety of avian and mammalian hosts including up to one third of the human population worldwide. Developmental differentiation between distinct stages, i.e. sporozoites, tachyzoites and bradyzoites is fundamental for the parasite life cycle and for transmission between hosts. It is also interconnected with the pathogenesis of overt toxoplasmosis and makes T. gondii an important opportunistic pathogen of humans. In order to delineate the underlying mechanisms, several cell culture differentiation systems have been developed which mimic the transition from fast-replicating tachyzoites to slowly proliferating bradyzoites in vitro. Since exogenous stress factors, i.e. alkaline pH, IFN-gamma and other proinflammatory cytokines, chemicals or drugs, heat shock, and deprivation of nutrients have been shown to increase the efficacy of bradyzoite development in vitro, Toxoplasma stage differentiation is largely viewed as a stress-related response to hostile environmental conditions. However, tachyzoite to bradyzoite differentiation also occurs spontaneously in vitro and this raises questions about the importance of stress conditions for triggering stage conversion. High frequencies of spontaneous bradyzoite development in primary and permanent skeletal muscle cells, i.e. cells that preferentially harbour bradyzoite-containing tissue cysts in vivo suggest that the host cell type may be critical. Furthermore, the host cell transcriptome, including the expression of distinct host cell genes, has recently been shown to trigger bradyzoite development and cyst formation. Together, these results strongly indicate that the complex cellular environment, besides exogenous stress factors, may govern the developmental differentiation of T. gondii.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633484     DOI: 10.1039/b800520f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  37 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

3.  Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner.

Authors:  Hany M Ibrahim; Hiroshi Bannai; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Optogenetic modulation of an adenylate cyclase in Toxoplasma gondii demonstrates a requirement of the parasite cAMP for host-cell invasion and stage differentiation.

Authors:  Anne Hartmann; Ruben Dario Arroyo-Olarte; Katharina Imkeller; Peter Hegemann; Richard Lucius; Nishith Gupta
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

5.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

6.  Targeted disruption of Toxoplasma gondii serine protease inhibitor 1 increases bradyzoite cyst formation in vitro and parasite tissue burden in mice.

Authors:  Viviana Pszenny; Paul H Davis; Xing W Zhou; Christopher A Hunter; Vern B Carruthers; David S Roos
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

Review 7.  Cell type- and species-specific host responses to Toxoplasma gondii and its near relatives.

Authors:  Zhee S Wong; Sarah L Sokol Borrelli; Carolyn C Coyne; Jon P Boyle
Journal:  Int J Parasitol       Date:  2020-05-11       Impact factor: 3.981

8.  Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.

Authors:  J A Portes; W De Souza
Journal:  Parasitol Res       Date:  2019-11-14       Impact factor: 2.289

9.  The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands.

Authors:  Min Zhang; Clare Fennell; Lisa Ranford-Cartwright; Ramanavelan Sakthivel; Pascale Gueirard; Stephan Meister; Anat Caspi; Christian Doerig; Ruth S Nussenzweig; Renu Tuteja; William J Sullivan; David S Roos; Beatriz M A Fontoura; Robert Ménard; Elizabeth A Winzeler; Victor Nussenzweig
Journal:  J Exp Med       Date:  2010-06-28       Impact factor: 14.307

10.  A novel co-infection model with Toxoplasma and Chlamydia trachomatis highlights the importance of host cell manipulation for nutrient scavenging.

Authors:  Julia D Romano; Catherine de Beaumont; Jose A Carrasco; Karen Ehrenman; Patrik M Bavoil; Isabelle Coppens
Journal:  Cell Microbiol       Date:  2012-11-27       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.